Targeted Therapies and Imaging Biomarkers: Revolutionizing ITP and Coronary Inflammation Management
Precision medicine is increasingly shaping clinical practice in both hematology and cardiology by promoting therapies and diagnostics rooted in disease mechanisms. In immune thrombocytopenia (ITP), rilzabrutinib, an oral Bruton tyrosine kinase inhibitor, represents a targeted strategy that addresses key drivers of the...